Tixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab...
30 KB (1,664 words) - 23:46, 14 October 2024
Tixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab...
90 KB (13,195 words) - 04:28, 26 July 2024
granted emergency use authorization (EUA) of the antibody drug tixagevimab/cilgavimab (Evusheld) to prevent COVID-19 in immunocompromised people who cannot...
8 KB (825 words) - 20:20, 1 November 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
16 KB (1,287 words) - 20:48, 11 November 2024
Obiltoxaximab J06BD01 Palivizumab J06BD02 Motavizumab J06BD03 Tixagevimab and cilgavimab J06BD04 Ansuvimab J06BD05 Sotrovimab J06BD06 Regdanvimab J06BD07...
2 KB (264 words) - 07:33, 31 December 2022
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
22 KB (2,320 words) - 13:06, 15 August 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
31 KB (2,777 words) - 08:32, 19 October 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
31 KB (2,632 words) - 22:56, 26 October 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
28 KB (2,721 words) - 04:14, 1 October 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
11 KB (972 words) - 19:24, 20 December 2023
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
10 KB (724 words) - 06:09, 16 July 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
10 KB (703 words) - 17:18, 20 April 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
14 KB (718 words) - 14:56, 19 July 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
20 KB (1,378 words) - 01:38, 31 October 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
8 KB (967 words) - 18:35, 12 August 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
44 KB (3,805 words) - 00:43, 23 July 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
24 KB (1,917 words) - 17:27, 12 October 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
42 KB (3,798 words) - 13:29, 20 November 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
16 KB (1,367 words) - 13:26, 14 October 2024
monoclonal antibody therapies (with the exception of sotrovimab and tixagevimab/cilgavimab) were not likely to be active against the Omicron variant. Over...
48 KB (4,964 words) - 04:26, 20 October 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
13 KB (1,026 words) - 03:24, 17 June 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
10 KB (836 words) - 03:56, 30 September 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
14 KB (1,191 words) - 05:34, 18 July 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
24 KB (2,132 words) - 11:10, 7 September 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
42 KB (3,486 words) - 00:32, 30 September 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
30 KB (2,678 words) - 01:11, 12 November 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
38 KB (3,716 words) - 20:23, 11 November 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
9 KB (800 words) - 20:50, 24 October 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
10 KB (778 words) - 01:56, 27 September 2024
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast...
41 KB (3,286 words) - 20:48, 11 November 2024